Skip to content
OpenCapital
Get started

Arcutis Biotherapeutics, Inc. ARQT EPS (Basic)

EPS (Basic) at other companies

Pfizer logo
PfizerPFE
$0.47-9.6%
Amgen logo
AmgenAMGN
$3.37+4.7%
Incyte logo
IncyteINCY
$1.52+85.4%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
-$1.18-45.7%
Arcus Biosciences logo
Arcus BiosciencesRCUS
-$1.02+10.5%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-$1.84-17.2%

Other financials

Income statement

See full
Revenue$105.4M+60.1%
Gross profit$95.6M+67.7%
Operating income-$9.1M+62.9%
Net income-$11.3M+54.9%
EPS (diluted)-$0.09+55.0%

Balance sheet

See full
Cash & equivalents$35.1M-34.7%
Total debt$114.7M+3.5%
Total equity$189.6M+32.9%
Total assets$460.0M+33.7%

Cash flow

See full
Operating cash flow$2.2M+107%
CapEx--100%
Free cash flow$2.2M+107%

Valuation

See full
Market cap$3.29B+57.5%

Profitability

See full
Gross margin90.9%+2.5pp
Operating margin-12%-5.7pp
Net margin-13.9%-6.6pp
FCF margin-52.5%-21.9pp

Returns & leverage

See full
Return on equity-28.2%-13.0pp
Debt / equity0.6×-0.2×
Current ratio2.7×-0.9×

Where this comes from

Reported directly by Arcutis Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.

The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcutis Biotherapeutics, Inc.'s eps (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arcutis Biotherapeutics, Inc.'s EPS (basic)?
Arcutis Biotherapeutics, Inc. (ARQT) reported EPS (basic) of -$0.09 in Q1 2026.
How has Arcutis Biotherapeutics, Inc.'s EPS (basic) changed year-over-year?
Arcutis Biotherapeutics, Inc.'s EPS (basic) increased by 55.0% year-over-year, from -$0.20 to -$0.09.
What is the long-term trend for Arcutis Biotherapeutics, Inc.'s EPS (basic)?
Over 3 years (2021 to 2024), Arcutis Biotherapeutics, Inc.'s EPS (basic) has grown at a -34.9% compound annual growth rate (CAGR), from -$4.17 to -$1.15.
What does EPS (basic) mean?
Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.